Biotechnology News

September 6, 2012

ST. LOUIS--(BUSINESS WIRE)--Christine Garnett joins Certara to lead development of cardiac safety modeling tools, work closely with consulting team on predictive modeling engagements to assess cardiac proarrhythmic risk.

September 6, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage biopharmaceutical company focused on developing multi-indication therapeutics in oncology and CNS, today announced that it will present at the Rodman...

September 6, 2012

MORRISTOWN, N.J.--(BUSINESS WIRE)--Durata has completed on schedule target enrollment for its DISCOVER 1 Phase 3 clinical trial, comparing the efficacy of Durata's dalbavancin to a regimen of vancomycin for the treatment of abSSSI.

September 6, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aileron Therapeutics, Inc. today announced the appointment of Hubert C. Chen, M.D., to vice president of clinical development, endocrine and metabolic disease. This strategic appointment comes as Aileron expands...

September 6, 2012

BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl, a subsidiary of Celgene Corporation (NASDAQ: CELG) today announced that statistical significance for the primary endpoint of ACR20 at week 16 was achieved for patients receiving...

September 6, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today announced the U.S. launch and first commercial sales of MEDIHONEY® HCS (Hydrogel Colloidal...

September 6, 2012

PITTSBURGH--(BUSINESS WIRE)--Precision Therapeutics has released the results of a study that determines whether ChemoFx® results change from primary diagnosis to recurrence of disease in gynecological tumors with intervening administration of...

September 6, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology today announced the successful...

September 6, 2012

HACKENSACK, N.J.--(BUSINESS WIRE)--ADMA Biologics, Inc. (ADMA), a late-stage biotechnology company focused on the development and commercialization of human plasma and plasma-derived therapeutics, today announced it is scheduled to present at the...

September 6, 2012

FRAMINGHAM, Mass.--(BUSINESS WIRE)--AB Sciex and Sigma-Aldrich Announce Distribution Agreement

September 6, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--New Interventional Medical Device That Gently and Simply Treats Chronic Sinusitis Is Now Available in Europe.

September 6, 2012

NEWTOWN, Pa.--(BUSINESS WIRE)--Isis Pharmaceuticals is expanding its current use of BioClinica's Express Electronic Data Capture (EDC) solution to a broader range of upcoming clinical trials.

September 6, 2012

SAN RAMON, Calif.--(BUSINESS WIRE)--Estech, a leading provider of minimally invasive cardiac ablation devices, today announced the market release of its COBRA Fusion™ ablation system. This revolutionary technology is the first of its kind to use...

September 6, 2012

KARLSRUHE, Germany--(BUSINESS WIRE)--Findings by French scientists suggest that protection against Alzheimer´s disease can only be expected following long-term regular use of Ginkgo Extract EGb 761®. Use for a minimum of four years nearly halved...

September 6, 2012

BERKELEY, Calif.--(BUSINESS WIRE)--Aduro BioTech, Inc. announces the award of a Congressionally Directed Medical Research Programs (CDMRP) grant from the Department of Defense. The grant of $867,846 will be used to complete the preclinical...

September 6, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and neurotrauma conditions, today announced that CEO Frank Reynolds...

September 6, 2012

VANCOUVER, British Columbia--(BUSINESS WIRE)--Zymeworks Inc. today announced the successful achievement of a research milestone in its collaboration with Merck, known as MSD outside of the United States and Canada, related to Zymeworks’...

September 6, 2012

VANCOUVER, British Columbia--(BUSINESS WIRE)--Zymeworks Inc., a privately held biotherapeutics company focused on the development of best-in-class bi-specific antibody therapeutics and multi-valent protein therapeutics, today announced the...

September 6, 2012

SOUTHAMPTON, England--(BUSINESS WIRE)--Karus Therapeutics, a leader in the development of innovative medicines for the treatment of inflammatory disease and cancer, announces the closing of its Series B investment, which includes a first tranche...

September 6, 2012

SHANGHAI--(BUSINESS WIRE)--Generon Corporation announced the initiation of a Phase I clinical trial for F-652. F-652 is a recombinant protein containing a human interleukin-22 dimer, a first in class candidate, for hepatitis.

September 6, 2012

BOSTON & GENEVA--(BUSINESS WIRE)--PHT Corporation announced a 36% increase in revenues in the 1st half of 2012 over the same period last year. Bookings rose 27%. Global headcount expanded by 29%.

September 6, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: The Extraordinary General Meeting (EGM) of Fingerprint Cards AB (STO:FINGB) (publ) (the “Company”) has approved a private placement of share warrants and has resolved to approve the transfer of share...

September 6, 2012

COPENHAGEN, Denmark--(BUSINESS WIRE)--Symphogen A/S, a private biopharmaceutical company developing recombinant antibody mixtures, a class of antibody therapeutics under investigation for the treatment or prophylaxis of serious human diseases...

September 6, 2012

VISTA, Calif. & OXFORD, England--(BUSINESS WIRE)--Aperio ePathology NETWORK to improve communication among pathologists, pathology sub-specialists and other physicians.

September 5, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com, a medical device company focused on the diagnosis and treatment of the neurological...

September 5, 2012

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the Morgan Stanley Global Healthcare Conference in New York. John F. Milligan, PhD, Gilead’s President...

September 5, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals to Present at Upcoming Investor Conferences to Provide Business and Development Program Updates

September 5, 2012

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Senesco Technologies, Inc. (“Senesco” or the “Company”) (NYSE MKT: SNT) announced that the Company will be presenting at the Rodman & Renshaw Annual Global Investment Conference being held at the Waldorf...

September 5, 2012

OTTAWA, Ontario--(BUSINESS WIRE)--Nordion Inc. (TSX: NDN) (NYSE: NDZ): Revenue of $67.1 million, an increase of 0.5% over Q3 2011 Adjusted earnings per share, excluding specified items, increased to $0.25, up from $0.15 in the third quarter...

September 5, 2012

ANN ARBOR, Mich.--(BUSINESS WIRE)--Online Tech, the leader in secure and compliant data hosting services, has taken another step to differentiate itself from its competitors. The Ann Arbor, Mich.-based data center expanded its compliant computing...

September 5, 2012

COLD SPRING HARBOR, N.Y.--(BUSINESS WIRE)--As part of a huge collaborative effort called ENCODE (Encyclopedia of DNA Elements), a research team at CSHL has analyzed all the RNA messages, called transcripts, produced within human cells.

September 5, 2012

HOUSTON--(BUSINESS WIRE)--Smart Imaging Technologies has signed a license agreement with Leica Microsystems and added support for Leica Slide Scanners to Simagis Live Digital Pathology Servers.

September 5, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care announced today that Edward J. Quilty, the Company’s chief executive officer will present a...

September 5, 2012

DAVIS, Calif.--(BUSINESS WIRE)--Simplify and improve your clinical laboratory with single-step, direct ELISA measurement of Free Testosterone from Gold Standard Diagnostics (GSD)

September 5, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--Penumbra Coil 400 enables endovascular surgeons to implant fewer coils, during shorter procedures, and achieve better results significantly improving minimally invasive brain aneurysm treatment.

September 5, 2012

WILMINGTON, N.C.--(BUSINESS WIRE)--Myo Technologies, LLC Introduces Non-Invasive Microcurrent Skin Toning Treatment and Botanical Skin Care Products for Medical Professional Use, Pre- and Post-Surgery

September 5, 2012

LEBANON, N.H.--(BUSINESS WIRE)--ImmuNext - Janssen Biotech partnership to develop novel therapeutics that modulate the immune system for the treatment of cancer.

September 5, 2012

TORONTO--(BUSINESS WIRE)--New Enterprise Cloud Infrastructure Service Contract with SunGard Sets Stage for the North American Launch of the HeartCheckTM PEN SMART Monitoring Service

September 5, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion) today announced that it has completed the company’s acquisition, by merger, of Elevation Pharmaceuticals, Inc. (Elevation). Elevation is now a wholly-owned subsidiary...

September 5, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq: XNPT) announced today that it will provide access via the World Wide Web to its presentation at the Morgan Stanley Global Healthcare Conference. The live presentation will occur at 12:...

September 5, 2012

SAN FRANCISCO--(BUSINESS WIRE)--FibroGen, Inc., on Monday, September 3rd, presented the most recent results from its Phase 2 trial of FG-3019 as an oral presentation at the European Respiratory Society Annual Congress in Vienna, Austria. The...

September 5, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Desktop DNA sequencing company GnuBIO moves towards commercialization of the first no prep desktop DNA sequencer. The company is moving to a larger facility in Cambridge, MA - Kendall Square.

September 5, 2012

SAN FRANCISCO--(BUSINESS WIRE)--ClinStar to Present a Comparison of Study Start-Up in Emerging Markets with at Outsourcing Clinical Trials New England Conference Followed by a Seminar on Optimizing Time and Money in Clinical Trials

September 5, 2012

EXTON, Pa.--(BUSINESS WIRE)--BioTrends Research Group, one of the world’s leading research and advisory firms for specialized biopharmaceutical issues, finds that Roche/Genentech’s Perjeta (pertuzumab) which has been available in the U.S. for one...

September 5, 2012

VALLEY FORGE, Pa.--(BUSINESS WIRE)--Vanguard announced today that Edward P. Owens, CFA, portfolio manager of Vanguard Health Care Fund, plans to retire on December 31, 2012.

September 5, 2012

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX) previously announced that it will host its 2012 Investor Conference on Tuesday, October 9, 2012 at the Ritz-Carlton Hotel in Chicago, IL, from 8:00 a.m. until approximately 3...

September 5, 2012

OKLAHOMA CITY--(BUSINESS WIRE)--The new Magellan(TM) prosthetic leg from Orthocare Innovations brings novel approach by mimicking key features of the human ankle and offers wireless connectivity.